Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
---|
06/11/1997 | EP0394409B1 Macrophage-derived inflammatory mediator (mip-2) |
06/11/1997 | CN1151760A Serum paraoxonase |
06/11/1997 | CN1151759A Antibodies which bind to insect jut proteins and their use |
06/10/1997 | US5637686 Tata-binding protein associated factor, nucleic acids |
06/10/1997 | US5637677 Biologically active compounds and methods of constructing and using the same |
06/10/1997 | US5637569 Ganglioside analogs |
06/10/1997 | US5637493 Carcinoma associated antigen (SK1) monoclonal antibodies against SK1, methods of producing these antibodies and use therefor |
06/10/1997 | US5637487 Genetic engineered polypeptide; used for immunization of chickens against coccidiosis |
06/10/1997 | US5637481 Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell |
06/10/1997 | US5637470 Screening array using cells expressing recombinant α and β subunits of the mammalian large-conductance (maxi-K) potassium channel |
06/10/1997 | US5637455 HIV-2 virus variants |
06/10/1997 | US5637300 Contraceptive vaccine comprising a glycosylated 55 kD zona pellucida protein immunogen and method of use of the same in contraception |
06/05/1997 | WO1997020078A1 Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
06/05/1997 | WO1997020063A1 THEREAPEUTIC APPLICATIONS FOR THE ANTI-T-BAM (CD40-L) MONOCLONAL ANTIBODY 5c8 |
06/05/1997 | WO1997020054A1 Recombinant poxvirus-feline infectious peritonitis virus, compositions thereof and methods for making and using them |
06/05/1997 | WO1997020048A2 Modified sfv molecules which mediate adhesion between cells and uses thereof |
06/05/1997 | WO1997020041A1 Method for solubilizing proteins in organic solvents |
06/05/1997 | WO1997019957A1 High efficiency tissue specific compound delivery system using streptavidin-protein a fusion protein |
06/05/1997 | WO1997019952A1 The ob receptor and methods of diagnosing and treating weight |
06/05/1997 | WO1997019950A1 Topiramate immunoassay, as well as analogs and antibodies |
06/05/1997 | WO1997012036A3 Bone stimulating factor |
06/05/1997 | CA2238569A1 The ob receptor and methods of diagnosing and treating weight |
06/05/1997 | CA2238568A1 Method for solubilizing proteins in organic solvents |
06/04/1997 | EP0776972A1 GENE CODING FOR IgG-Fc-BINDING PROTEIN |
06/04/1997 | EP0776906A2 Sm-D peptide antigens and their use especially in the diagnosis of systemic lupus erythromatodes |
06/04/1997 | EP0776370A1 Human erythropoietin receptor fragment and antibodies thereto |
06/04/1997 | EP0776366A1 Chimeric proteins and muteins of tissue factor pathway inhibitors tfpi and tfpi-2 |
06/04/1997 | EP0776365A2 Retinoblastoma protein-interacting zinc finger proteins |
06/04/1997 | EP0776364A1 Glutamate receptor |
06/04/1997 | EP0776338A1 Immunoconjugates comprising tyrosine kinase inhibitors |
06/04/1997 | EP0776337A1 Growth differentiation factor-11 |
06/04/1997 | EP0776336A1 Vitronectin binding protein |
06/04/1997 | EP0776217A1 A method of treating a patient with a biologically active compound |
06/04/1997 | EP0776209A1 Polynucleic acids and proteins from a porcine reproductive and respiratory syndrome virus and uses thereof |
06/04/1997 | EP0680607A4 Assay method to rule out rupture of membranes in women at risk for imminent delivery. |
06/04/1997 | EP0544861A4 Immunoassay for non-a non-b hepatitis |
06/04/1997 | EP0411018B1 Detection, quantitation and classification of ras proteins in body fluids and tissues |
06/04/1997 | CN1151184A Human Monoclonal antibodies specific to cell cycle independent glioma surface antigen |
06/04/1997 | CN1151183A RPS 2 gene and uses thereof |
06/04/1997 | CN1151167A Isolated MAGE-3 derived peptides which complex with HLA-A2 molecules and uses thereof |
06/04/1997 | CN1151120A Method and compositions useful for inhibition of angiogenesis |
06/03/1997 | US5635617 Methods and compositions comprising the agfA gene for detection of Salmonella |
06/03/1997 | US5635603 Antibody fragment covalently bound to diagnostic or therapeutic principle through carbohydrate moiety |
06/03/1997 | US5635602 Design and synthesis of bispecific DNA-antibody conjugates |
06/03/1997 | US5635601 Beta-8 integrin subunit antibodies |
06/03/1997 | US5635600 Bifunctional and heteroantibodies specific for the high affinity Fc receptor for immunoglobulin G on human mononuclear phagocytes |
06/03/1997 | US5635599 Circularly permuted il4, il2, granulocyte macrophage colony stimulating factor or granulocyte colony stimulating factor fused to a cytotoxin, i.e., pseudomonas exotoxin, diphtheria toxin without the native receptor-binding domain; cancer |
06/03/1997 | US5635388 Monoclonal antibody produced by a hybridoma cell binds to the extracellular domain of flk2/flk3 and activates the intracellular tyrosine kinase domain enhancing repopulation of myeloid and lymphoid blood cell lineages with cytokines |
06/03/1997 | US5635374 Bone calcification factor and recombinant production of the factor nucleic acid encoding |
06/03/1997 | US5635372 BMP-15 compositions |
06/03/1997 | US5635359 Method for measuring the activity of angiotensin converting enzyme in biological samples |
06/03/1997 | US5635345 Isolation of lymphocytes, incubation with labeled monoclonal antibody to a prosomal protein, measuring percentage of cells having this protein on cell surface, comparison with non-infected cells, human immunodeficiency virus, kits |
06/03/1997 | US5635181 Pure immunogenic peptide encoded by dna sequence present in specified recombinant bacterial plasmid |
06/03/1997 | US5635178 Inhibition of complement mediated inflammatory response using monoclonal antibodies specific for a component forming the C56-9 complex which inhibit the platelet or endothelial cell activating function of the C56-9 complex |
06/03/1997 | US5635177 Useful in enabling role of tyrosine kinase receptor in cell growth and differentiation |
05/29/1997 | WO1997019177A1 SYNTHETIC MAMMALIAN α-N-ACETYLGLUCOSAMINIDASE AND GENETIC SEQUENCES ENCODING SAME |
05/29/1997 | WO1997019171A1 Epithelial membrane protein-1 |
05/29/1997 | WO1997019170A1 Receptor and nucleic acid molecule encoding said receptor |
05/29/1997 | WO1997019168A1 Sequestrin |
05/29/1997 | WO1997019113A2 Monoclonal antiidiotypic antibodies (ab2) and uses thereof |
05/29/1997 | WO1997019112A1 Inhibitory and non-inhibitory antigen binding polypeptides against human p450 enzymes |
05/29/1997 | WO1997019111A2 Monoclonal antibodies anti-cd6 and their uses |
05/29/1997 | WO1997019110A1 Materials and methods relating to the identification and sequencing of the brca2 cancer susceptibility gene and uses thereof |
05/29/1997 | WO1997019101A1 Novel grb2 associating polypeptides and nucleic acids encoding therefor |
05/29/1997 | WO1997019100A1 N-1-carboxyalkyl derivatives of lsd |
05/29/1997 | WO1997018838A1 Therapeutic uses of humanized antibodies against alpha-4 integrin |
05/29/1997 | WO1997018833A1 Methods of increasing lean tissue mass using ob protein compositions |
05/29/1997 | WO1997018826A1 Fine tuned protegrins |
05/29/1997 | WO1997018825A1 PROTEIN WHICH INTERACTS WITH THE HUNTINGTON'S DISEASE GENE PRODUCT, cDNA CODING THEREFOR, AND ANTIBODIES THERETO |
05/29/1997 | WO1997018822A1 Vertebrate deltex proteins, nucleic acids, and antibodies, and related methods and compositions |
05/29/1997 | WO1997018799A1 Use of a tnf alpha antagonist for treating neurogenic skin redness |
05/29/1997 | WO1997009343A3 Antagonists of the oncogenic activity of the protein mdm2, and use thereof in the treatment of cancers |
05/29/1997 | CA2629643A1 Inhibitory and non-inhibitory antigen binding polypeptides against human p450 enzymes |
05/29/1997 | CA2358862A1 Methods of increasing lean tissue mass using ob protein compositions |
05/29/1997 | CA2238610A1 Fine tuned protegrins |
05/29/1997 | CA2238404A1 Vertebrate deltex proteins, nucleic acids, and antibodies, and related methods and compositions |
05/29/1997 | CA2238075A1 Protein which interacts with the huntington's disease gene product, cdna coding therefor, and antibodies thereto |
05/29/1997 | CA2238010A1 Materials and methods relating to the identification and sequencing of the brca2 cancer susceptibility gene and uses thereof |
05/29/1997 | CA2237808A1 Therapeutic uses of humanized antibodies against alpha-4 integrin |
05/29/1997 | CA2236163A1 Methods of increasing lean tissue mass using ob protein compositions |
05/29/1997 | CA2236162A1 Epithelial membrane protein-1 |
05/29/1997 | CA2210705A1 Monoclonal antiidiotypic antibodies (ab2) and their uses |
05/28/1997 | EP0775750A2 Preparation of proteins from pro-proteins by fusion proteins derived from furin or furinanalogs |
05/28/1997 | EP0775747A2 Genes of the hop latent virus and methods for detecting the same |
05/28/1997 | EP0775746A2 Coccidiosis poultry vaccine |
05/28/1997 | EP0775742A2 Inhibiting transforming growth factor beta to prevent accumulation of axtracellular matrix |
05/28/1997 | EP0775205A1 Novel cell surface receptor, antibody compositions, and methods of using same |
05/28/1997 | EP0775202A1 Human interleukin variants generated by alternative splicing |
05/28/1997 | EP0775199A1 Superoxide dismutase-4 |
05/28/1997 | EP0674734B1 Ski slope maintenance device |
05/28/1997 | EP0670892A4 PURIFICATION, COMPOSITION AND SPECIFICITY OF HEPARINASE I, II, AND III FROM -i(FLAVOBACTERIUM HEPARINUM). |
05/28/1997 | EP0653064A4 Clinical test for detection of alzheimer's disease. |
05/28/1997 | EP0571420B1 Mycobacterium polypeptides and nucleic acids encoding them for diagnosis and control of tuberculosis |
05/28/1997 | EP0517918B1 Monoclonal antibody against cardiac glycoside and utilization thereof |
05/28/1997 | EP0512112B1 Anti cd-4 antibodies blocking hiv-induced syncytia |
05/28/1997 | EP0455705B1 Receptor membranes and ionophore gating |
05/28/1997 | EP0403554B1 Placental isoferritins for the prognosis and diagnosis of immunosuppression |
05/28/1997 | CN1150840A A method for detecting presence of mycobacterium species and kit and antibodies for use therein |
05/28/1997 | CN1150805A Isolated peptides derived from MAGE tumor rejection antigen precursops which complex with HLA-A2 molecules |
05/28/1997 | CN1150804A Fibroblast growth factor-10 |